Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire

BACKGROUND: Coronavirus disease 2019 (COVID-19) lockdowns disrupted access to harm reduction supplies and services known to be effective in overdose prevention and contributed to a worsening of the opioid crisis. However, because pharmacies can provide naloxone and sell over-the-counter (OTC) steril...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolivar, Derek, Hartung, Daniel, Silcox, Joseph, Bratberg, Jeffrey, Boggis, Jesse, Rabin, Megan, Green, Traci C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574786/
https://www.ncbi.nlm.nih.gov/pubmed/36369076
http://dx.doi.org/10.1016/j.japh.2022.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574786/
https://www.ncbi.nlm.nih.gov/pubmed/36369076
http://dx.doi.org/10.1016/j.japh.2022.10.012

Ejemplares similares